Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003–2006

References

Page 1

	Year	Citations
Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) Scott M. Grundy JAMA Metabolic SyndromeHypertensionSecond ReportPrimary PreventionCardiovascular Disease	1993	27.9K
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Evaluation Expert Panel on Detection JAMA OtorhinolaryngologyHyperlipidemiaSurgeryMedical DiagnosisWebsite Uses Cookies	2001	25.8K
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Anders Olsson, John J.V. McMurray, G Thorgeirsson, The Lancet Cardiovascular DiseaseHealth PolicyHyperlipidemiaDyslipidemiaPreventive Cardiology	1994	8.5K
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, New England Journal of Medicine	1996	7.5K
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia James Shepherd, Stuart M. Cobbe, Ian Ford, New England Journal of Medicine	1995	7.5K
Heart Disease and Stroke Statistics—2011 Update Véronique L. Roger, Alan S. Go, Donald M. Lloyd‐Jones, Circulation	2010	6.2K
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels John R. Downs, Michael Clearfield, Stephen E. Weis, JAMA	1998	5.3K
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Terje R. Pedersen Atherosclerosis Supplements Cardiovascular DiseaseHealth PolicyHyperlipidemiaDyslipidemiaPreventive Cardiology	2004	3.1K
West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials The Lancet Percutaneous Coronary InterventionHigh-risk GroupsPreventive MedicineCardiovascular EpidemiologyCardiovascular Disease	1996	1.6K
American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update : a report from the American Heart Association V Vl Roger Circulation ThrombosisCardiovascular EpidemiologyIschemic StrokeCardiovascular DiseaseMedicine	2011	719

Page 1